The UK Focal Point on Drugs' (part of Public Health England) annual report on the United Kingdom drug situation, providing updates for 2017. The report contains details of hepatitis C prevalence and incidence rates among injecting drug users, levels of testing, diagnosis and treatment for hepatitis C and prevention efforts by UK governments.
BVHG/BASL Best Practice for ODN Stakeholders Meeting
Download
In January 2018, the British Viral Hepatitis Group (BVHG) and the British Association for the Study of the Liver (BASL) held their first Best Practice for ODN Stakeholders meeting in Manchester, attended by ODN representatives from across
the country, along with representatives from NHS England, patient advocacy groups and industry. This report summarises the key themes that emerged from the meeting and highlights examples of best practice for treating hepatitis C. The report also makes suggestions for a modified and improved approach to achieving hepatitis C elimination in England, with a series of recommendations focusing on three areas: testing and treatment; education, communication and engagement;
and management and administration.
